PARP1 and cardiovascular disorder: For instance, in aging rats, treatment with the PARP inhibitor INO-1001 reduces cardiovascular disorders [126], and treatment with the PARP inhibitor PJ34 improves myocardial contractile function and restores endothelial function [127].